Search bioRxiv⌕ Search

Biology subjects

Huntington, J. A.

Publications and source records attributed to Huntington, J. A..

2 recordsLinked to original sources

Prothrombinase processivity is conferred by substrate allostery

Conversion of prothrombin to thrombin occurs in the final step of the blood coagulation cascade and depends on association of the serine protease, factor (f) Xa, and the cofactor fVa on activated cell surfaces to form the prothrombinase complex. Prothrombinase cleaves prothrombin at two sites in a processive manner [~]500,000-times faster than fXa on its own. How fVa confers rapid and processive cleavage of prothrombin is an enzymatical mystery with profound consequence. We created a variant of fXa that binds to fVa with high affinity in the absence of phospholipids that preserves the activity of wild-type prothrombinase, and recently reported on the cryo-EM structure of the complex. It revealed an extensive interface between the two proteins, including a critical interaction between the first acidic region C-terminal to the A2 domain of fVa (the N-terminal portion of the a2-loop) with the heparin binding site of fXa. Here we present the cryo-EM structures of prothrombinase bound to prothrombin and the intermediate meizothrombin, both to 3.1 [A] resolution. The prothrombin complex revealed a surprising interaction between the second acidic region of the a2-loop with exosite I of prothrombin, accounting for 70% of the total buried surface area. Cleavage at Arg320 triggers the zymogen-to-protease conformational change in meizothrombin which alters all domain-domain and fVa interactions, and results in the presentation of the second cleavage site (Arg271) for processing. Together, these structures reveal a remarkable enzymatic mechanism that depends on the active participation of the substrate itself, and introduce the new paradigm of substrate allostery.

biochemistry↗

Engineering a membrane-independent human prothrombinase through parsimonious mutation of factor Xa

BackgroundThrombin is generated from its precursor prothrombin by sequential cleavage at Arg320 and Arg271 by the prothrombinase complex, composed of factor (f) Xa and fVa on phospholipid (PL) membrane surfaces. The affinity of human fXa for fVa is low in the absence of PL. However, fXa orthologues from the venom of group D snakes bind to fVa with high affinity, forming an active complex without PL. We previously characterized the properties of the fXa orthologue Hopsarin D (HopD) from Hoplocephalus stephensii. ObjectivesHere we set out to create a PL-independent human prothrombinase by making mutations to fXa, guided by a model of the prothrombinase complex and the sequence differences between human fXa and HopD. MethodsWe assessed the contribution of individual domains of fXa to its binding to fVa by swapping each with the corresponding domain of HopD. We then chose three loops in the serine protease (SP) domain predicted to be in contact with fVa to swap to those of HopD. Eventually, 10 residues from the three loops in the SP domain and 7 from the EGF2 domain were selected for mutation. ResultsThe resulting M17 fXa variant bound to fVa with a Kd of ~20 nM, similar to HopD, and together efficiently processed prothrombin through the meizothrombin intermediate in the absence of PL. ConclusionsWe conclude that the role of PL membranes in prothrombinase assembly and function is limited to improving the affinity of fXa for fVa. The M17-fVa complex is likely to be structurally equivalent to the human prothrombinase complex.

biochemistry↗